Cargando…
Is the (18)F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?
Autor principal: | Buchpiguel, Carlos Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522252/ https://www.ncbi.nlm.nih.gov/pubmed/29166452 http://dx.doi.org/10.1590/2359-3997000000300 |
Ejemplares similares
-
Is (18)F-FDG PET/CT a real breakthrough imaging test in
predicting the outcome of percutaneous ablation of metastases?
por: Buchpiguel, Carlos Alberto
Publicado: (2019) -
Complementary findings on (18)F-FDG PET/CT and
(18)F-NaF PET/CT in a patient with Erdheim-Chester
disease
por: Sabino, Daniela, et al.
Publicado: (2017) -
(18)F-FDG PET/CT in the Follow-Up of Mucosal Leishmaniasis
por: Camargo, Raphael A., et al.
Publicado: (2018) -
The Use of (18)F-FDG PET/CT in Patients with Recurrent Differentiated Thyroid Cancer
por: Ekmekçioğlu, Özgül
Publicado: (2021) -
Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for Localizing Recurrence in Patients with Differentiated Thyroid Carcinoma
por: Lee, Jandee, et al.
Publicado: (2012)